-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Neutral on Agilon Health, Lowers Price Target to $0.75

Benzinga·03/03/2026 18:06:50
Listen to the news
Citigroup analyst Daniel Grosslight maintains Agilon Health (NYSE:AGL) with a Neutral and lowers the price target from $0.85 to $0.75.